The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study.
 
Huikai Li
No Relationships to Disclose
 
Rentao Li
No Relationships to Disclose
 
Xihao Zhang
No Relationships to Disclose
 
Xiaojing Xie
No Relationships to Disclose
 
Junchao Yao
No Relationships to Disclose
 
Yang Liu
No Relationships to Disclose
 
Linlin Fu
No Relationships to Disclose
 
Qi Qi
No Relationships to Disclose
 
Xiaofeng Mu
No Relationships to Disclose
 
Yu Bai
No Relationships to Disclose